Business Description
Alterity Therapeutics Ltd
ISIN : AU0000043945
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 79.49 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.8 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | 33.1 | |||||
3-Year Book Growth Rate | -41.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 16.64 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.16 | |||||
9-Day RSI | 54.16 | |||||
14-Day RSI | 56.43 | |||||
6-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 3.54 | |||||
Cash Ratio | 2.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36 | |||||
Shareholder Yield % | -32.07 |
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
PB Ratio | 2 | |||||
EV-to-EBIT | -0.98 | |||||
EV-to-Forward-EBIT | -0.7 | |||||
EV-to-EBITDA | -0.99 | |||||
EV-to-FCF | -1.16 | |||||
Earnings Yield (Greenblatt) % | -102.04 | |||||
FCF Yield % | -52.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Alterity Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | 0 | ||
Beta | 1.47 | ||
Volatility % | 121.77 | ||
14-Day RSI | 56.43 | ||
14-Day ATR (A$) | 0.00094 | ||
20-Day SMA (A$) | 0.005425 | ||
12-1 Month Momentum % | -50 | ||
52-Week Range (A$) | 0.002 - 0.008 | ||
Shares Outstanding (Mil) | 5,245.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Alterity Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Alterity Therapeutics Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Alterity Therapeutics Ltd Frequently Asked Questions
What is Alterity Therapeutics Ltd(ASX:ATH)'s stock price today?
When is next earnings date of Alterity Therapeutics Ltd(ASX:ATH)?
Does Alterity Therapeutics Ltd(ASX:ATH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |